vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与Spero Therapeutics, Inc.（SPRO）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是Spero Therapeutics, Inc.的1.1倍（$13.7M vs $12.6M），Spero Therapeutics, Inc.净利率更高（250.7% vs -10.3%，领先261.0%），Spero Therapeutics, Inc.同比增速更快（24080.8% vs 31.1%），过去两年Spero Therapeutics, Inc.的营收复合增速更高（847.7% vs 26.9%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
CPIX vs SPRO — 直观对比
营收规模更大
CPIX
是对方的1.1倍
$12.6M
营收增速更快
SPRO
高出24049.7%
31.1%
净利率更高
SPRO
高出261.0%
-10.3%
两年增速更快
SPRO
近两年复合增速
26.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $12.6M |
| 净利润 | $-1.4M | $31.5M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | — |
| 净利率 | -10.3% | 250.7% |
| 营收同比 | 31.1% | 24080.8% |
| 净利润同比 | 25.8% | 250.9% |
| 每股收益（稀释后） | $-0.09 | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXSPRO
| Q4 25 | $13.7M | $12.6M | ||
| Q3 25 | $8.3M | $0 | ||
| Q2 25 | $10.8M | $0 | ||
| Q1 25 | $11.7M | $12.0K | ||
| Q4 24 | $10.4M | $52.0K | ||
| Q3 24 | $9.1M | $65.0K | ||
| Q2 24 | $9.8M | $114.0K | ||
| Q1 24 | $8.5M | $140.0K |
净利润CPIXSPRO
| Q4 25 | $-1.4M | $31.5M | ||
| Q3 25 | $-1.9M | $-7.4M | ||
| Q2 25 | $-740.7K | $-1.7M | ||
| Q1 25 | $1.3M | $-13.9M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-1.5M | $-17.1M | ||
| Q2 24 | $-1.1M | $-17.9M | ||
| Q1 24 | $-1.9M | $-12.7M |
毛利率CPIXSPRO
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXSPRO
| Q4 25 | -10.0% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -6.9% | — | ||
| Q1 25 | 11.0% | -122758.3% | ||
| Q4 24 | -17.7% | — | ||
| Q3 24 | -18.6% | -28604.6% | ||
| Q2 24 | -10.4% | -16720.2% | ||
| Q1 24 | -22.0% | -9987.1% |
净利率CPIXSPRO
| Q4 25 | -10.3% | 250.7% | ||
| Q3 25 | -23.4% | — | ||
| Q2 25 | -6.8% | — | ||
| Q1 25 | 10.7% | -115550.0% | ||
| Q4 24 | -18.2% | — | ||
| Q3 24 | -17.0% | -26380.0% | ||
| Q2 24 | -11.0% | -15668.4% | ||
| Q1 24 | -22.9% | -9049.3% |
每股收益（稀释后）CPIXSPRO
| Q4 25 | $-0.09 | $0.56 | ||
| Q3 25 | $-0.13 | $-0.13 | ||
| Q2 25 | $-0.05 | $-0.03 | ||
| Q1 25 | $0.08 | $-0.25 | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $-0.11 | $-0.32 | ||
| Q2 24 | $-0.08 | $-0.33 | ||
| Q1 24 | $-0.14 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $40.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $59.0M |
| 总资产 | $76.8M | $68.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXSPRO
| Q4 25 | $11.4M | $40.3M | ||
| Q3 25 | $15.2M | $48.6M | ||
| Q2 25 | $16.1M | $31.2M | ||
| Q1 25 | $15.1M | $48.9M | ||
| Q4 24 | $18.0M | $52.9M | ||
| Q3 24 | $17.5M | $76.3M | ||
| Q2 24 | $17.3M | $63.5M | ||
| Q1 24 | $18.5M | $82.3M |
股东权益CPIXSPRO
| Q4 25 | $24.9M | $59.0M | ||
| Q3 25 | $26.1M | $26.5M | ||
| Q2 25 | $28.0M | $32.8M | ||
| Q1 25 | $28.7M | $33.8M | ||
| Q4 24 | $22.9M | $46.1M | ||
| Q3 24 | $24.8M | $65.5M | ||
| Q2 24 | $26.3M | $80.5M | ||
| Q1 24 | $27.5M | $96.2M |
总资产CPIXSPRO
| Q4 25 | $76.8M | $68.9M | ||
| Q3 25 | $65.9M | $54.2M | ||
| Q2 25 | $67.9M | $62.1M | ||
| Q1 25 | $69.9M | $77.7M | ||
| Q4 24 | $75.6M | $110.5M | ||
| Q3 24 | $76.7M | $135.2M | ||
| Q2 24 | $78.5M | $149.9M | ||
| Q1 24 | $81.5M | $167.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $-8.4M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | — |
| 自由现金流率自由现金流/营收 | 0.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | -0.26× |
| 过去12个月自由现金流最近4个季度 | $4.8M | — |
8季度趋势，按日历期对齐
经营现金流CPIXSPRO
| Q4 25 | $3.0K | $-8.4M | ||
| Q3 25 | $187.2K | $17.4M | ||
| Q2 25 | $843.8K | $-17.7M | ||
| Q1 25 | $3.9M | $-4.0M | ||
| Q4 24 | $1.9M | $-23.4M | ||
| Q3 24 | $475.5K | $12.8M | ||
| Q2 24 | $-855.7K | $-18.7M | ||
| Q1 24 | $-2.1M | $5.9M |
自由现金流CPIXSPRO
| Q4 25 | $3.0K | — | ||
| Q3 25 | $163.4K | — | ||
| Q2 25 | $817.3K | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $460.1K | — | ||
| Q2 24 | $-862.8K | — | ||
| Q1 24 | $-2.2M | — |
自由现金流率CPIXSPRO
| Q4 25 | 0.0% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 32.9% | — | ||
| Q4 24 | 18.2% | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | -8.8% | — | ||
| Q1 24 | -25.6% | — |
资本支出强度CPIXSPRO
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | — |
现金转化率CPIXSPRO
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
